-
公开(公告)号:US20150366983A1
公开(公告)日:2015-12-24
申请号:US14765931
申请日:2014-03-12
申请人: ELI LILLY & COMPANY , AMBRX, INC.
CPC分类号: A61K38/2264 , A61K47/60 , C07K14/5759
摘要: Modified canine leptin polypeptides and formulations and uses thereof, are provided including polyethylene glycol (PEG) modified canine leptin polypeptides, wherein the PEG moiety is covalently attached to a para-acetyl-phenylalanine (pAF) residue of the polypeptide, and related compositions and methods useful in treating companion animal obesity and other leptin-related disorders.
摘要翻译: 提供修饰的犬瘦素多肽及其制剂及其用途,包括聚乙二醇(PEG)修饰的犬瘦素多肽,其中PEG部分共价连接到多肽的对 - 乙酰基 - 苯丙氨酸(pAF)残基,以及相关组合物和方法 可用于治疗伴侣动物肥胖症和其他瘦素相关疾病。
-
公开(公告)号:US20190201491A1
公开(公告)日:2019-07-04
申请号:US16325345
申请日:2017-08-18
申请人: ELANCO US INC. , AMBRX, INC.
发明人: Peter Connor CANNING , Shailaja SRINAGESH , Anthony MANIBUSAN , Jason PINKSTAFF , Nickolas KNUDSEN
CPC分类号: A61K38/1825 , A61K38/00 , A61K38/18 , A61K47/10 , A61P3/00 , C07K14/503
摘要: The present application discloses PEG modified variants of a bFGF-21 polypeptide, compositions containing a bFGF-21 polypeptide variant, and methods useful in treating and/or preventing ketosis that administer the variant or a composition containing said bFGF-21 variant.
-
公开(公告)号:US20230340051A1
公开(公告)日:2023-10-26
申请号:US18102933
申请日:2023-01-30
申请人: Elanco US Inc. , Ambrx, Inc.
IPC分类号: C07K14/535 , A61K47/60 , A61P37/04 , A61P31/04 , A61K38/19
CPC分类号: C07K14/535 , A61K47/60 , A61P37/04 , A61P31/04 , A61K38/193
摘要: The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed.
-
公开(公告)号:US20210177980A1
公开(公告)日:2021-06-17
申请号:US17186642
申请日:2021-02-26
申请人: ELANCO US INC. , AMBRX, INC.
摘要: Disclosed herein are porcine interferon alpha variants (pINF-α) comprising a synthetic amino acid at select locations in pINF-α and a one or two amino acid insertion in the N-terminus after removal of the signal peptide. The pINF-α variants can further be pegylated. Methods of making and administering these compounds to treat virus infections in pigs and formulations comprising the variants are also provided.
-
公开(公告)号:US20210054039A1
公开(公告)日:2021-02-25
申请号:US16754357
申请日:2018-10-10
申请人: Elanco US Inc. , Ambrx, Inc.
IPC分类号: C07K14/535 , A61K38/19 , A61K47/60 , A61P37/04 , A61P31/04
摘要: The present invention relates to variants of porcine granulocyte colony stimulating factor (pG-CSF). The pG-CSF variants are useful in treating preventing or reducing the incidence of bacterial infections in swine. Methods of treating swine are disclosed.
-
公开(公告)号:US20190192673A1
公开(公告)日:2019-06-27
申请号:US16311540
申请日:2017-06-16
申请人: ELANCO US INC. , AMBRX, INC.
CPC分类号: A61K47/60 , A61K9/0019 , A61K38/00 , A61K47/02 , A61K47/10 , A61K47/12 , A61P31/14 , C07K14/56
摘要: Disclosed herein are porcine interferon alpha variants (pINF-α) comprising a synthetic amino acid at select locations in pINF-α and a one or two amino acid insertion in the N-terminus after removal of the signal peptide. The pINF-α variants can further be pegylated. Methods of making and administering these compounds to treat virus infections in pigs and formulations comprising the variants are also provided.
-
-
-
-
-